Delhi Doctors Talk Cannabis: Awshad’s 2023 Workshop Puts CBD on India’s Medical Map
Startup Awshad hosts training to bridge science and stigma in cannabis medicine.
Awshad medical cannabis workshop 2023 in Delhi gathered doctors to explore CBD therapies for pain, anxiety, and epilepsy, marking a milestone for cannabis education in India. The session also opened discussions on dosage, safety protocols, and integrating cannabis medicine into India’s healthcare system. Experts called it a crucial step in moving cannabis from taboo to trusted treatment.
In February 2023, Delhi-based startup Awshad made waves by organizing a first-of-its-kind medical cannabis workshop for doctors and healthcare professionals. The event focused on educating practitioners about CBD therapies for conditions such as chronic pain, anxiety disorders, epilepsy, and chemotherapy-related side effects.
The workshop highlighted how cannabis, long sidelined by stigma, is increasingly being validated through clinical evidence and international best practices. Experts noted that Awshad’s medical cannabis workshop 2023 was not just about awareness but about building confidence among India’s doctors to responsibly prescribe and guide patients in cannabis-based care.
Healthcare professionals at the event stressed the need for structured medical training, clear dosage guidelines, and regulatory support to fully integrate cannabis into mainstream medicine. For many, the workshop symbolized a shift: cannabis in India is moving from controversy to consultation.
Industry observers said such initiatives could fast-track India’s acceptance of cannabis medicine, positioning startups like Awshad at the center of the country’s emerging medical cannabis economy.
Referance
https://www.grandviewresearch.com/horizon/outlook/cannabidiol-market/india
